Back to top

BTIG says AtriCure should be ready to defend AtriClip share after Edwards nod

BTIG analyst Marie Thibault notes that the FDA’s 510(k) database reflected clearance of Edwards Lifesciences’ (EW) ECLIPTIS left atrial appendage e...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

AtriCure, Inc. (ATRC)

Edwards Lifesciences Corporation (EW)

iShares MSCI Switzerland ETF (EWL)

Medtronic PLC (MDT)